Dr. Kalb disclosed that he is an investigator and/or consultant for AbbVie, Amgen, Celgene, Dermira, Janssen, Leo, Merck, Pfizer, and Taro. He is also on the dermatology safety monitoring board for ApoPharma and Eli Lilly.
On Twitter @dougbrunk
Conference Coverage
Jury still out on effect of systemic psoriasis meds on MI risk
Publish date: September 9, 2014
EXPERT ANALYSIS AT PDA 2014